Back
Protagonist Therapeutics Vs. Allakos Industry Stock Comparison
Sell
48
PTGX
Protagonist Therapeutics
Last Price:
28.97
Seasonality Move:
24.27%
Sell
29
ALLK
Allakos
Last Price:
1.26
Seasonality Move:
-6.73%
Sell
48
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $28.93. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Allakos (ALLK)
is a Sell
Is Allakos a Buy, Sell or Hold?
- The current Allakos [ALLK] share price is $1.26. The Score for ALLK is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- ALLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $28.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
PTGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 52.01 | Buy |
Chaikin Money Flow: | 164433 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.36 - 30.76) | Sell |
Bollinger Bands (100): | (19.23 - 28.71) | Buy |
ALLK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 43.22 | Sell |
Chaikin Money Flow: | -485744 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.26 - 1.48) | Sell |
Bollinger Bands (100): | (1.19 - 2.57) | Sell |
PTGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.42 | Buy |
20-day SMA: | 29.53 | Sell |
50-day SMA: | 27.9 | Buy |
200-day SMA: | 21.75 | Buy |
8-day EMA: | 28.57 | Buy |
20-day EMA: | 28.8 | Buy |
50-day EMA: | 27.55 | Buy |
200-day EMA: | 22.77 | Buy |
ALLK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.3 | Sell |
20-day SMA: | 1.34 | Sell |
50-day SMA: | 1.32 | Sell |
200-day SMA: | 2.64 | Sell |
8-day EMA: | 1.3 | Sell |
20-day EMA: | 1.33 | Sell |
50-day EMA: | 1.5 | Sell |
200-day EMA: | 2.86 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
Allakos Earnings Growth & ALLK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.02 per share, an increase this year of $0.65 per share, and an increase next year of $0.52 per share.
Protagonist Therapeutics Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Allakos Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |